BioGenerator, the investment arm of BioSTL, has invested in EDIS Solutions, a health care IT startup, through the BioGenerator’s Concept Fund.

Officials wouldn’t disclose how much was invested, but the Concept Fund typically invests up to $25,000 per deal.

In the medical industry, EDIS stands for emergency department information systems. EDIS is developing a platform that uses pharmaceutical drug data and dissects it into an easy-to-use platform.

Nannette Musgrave, CEO of EDIS Solutions, said the funding would help the company develop its technology and refine its data integration solution as it moves toward commercialization. The funding will also help EDIS pursue client revenue moving forward.